Insmed Inc. (NASDAQ:INSM) ranks among billionaire Stanley Druckenmiller’s 10 best stock picks. On January 23, Roth/MKM began ...

Insmed (INSM) closed the last trading session at $161, gaining 0.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street ...

Analysts have set 12-month price targets for Insmed, revealing an average target of $224.19, a high estimate of $269.00, and ...

Consistent in their evaluation, an analyst from Morgan Stanley keeps a Equal-Weight rating on Insmed with a target price of ...

The latest update to our Insmed narrative shows only a slight reset in the numbers, with the blended fair value estimate ...

Investors in Insmed Inc (Symbol: INSM) saw new options become available today, for the December 2024 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is ...

It certainly seems like the TAM for Brinsupri has a lot of room to expand with a very well designed strategy to identify ...

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.

Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Global equity markets continued ...

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Insmed Incorporated (“Insmed” or “the Company”) (NASDAQ: INSM) ...

Investors in Insmed Inc (Symbol: INSM) saw new options begin trading today, for the July 2024 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the ...